Statin use and prognosis of lung cancer: a systematic review and meta-analysis of observational studies and randomized controlled trials

References

• ChenWZhengRBaadePDCancer statistics in China, 2015CA Cancer J Clin201666211513226808342
   PubMed Web of Science ®Google Scholar
• Cholesterol Treatment Trialists’ (CTT) CollaboratorsMihaylovaBEmbersonJThe effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomized trialsLancet2012380984158159022607822
   PubMed Web of Science ®Google Scholar
• MillsEJRachlisBWuPDevereauxPJAroraPPerriDPrimary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patientsJ Am Coll Cardiol200852221769178119022156
   PubMed Web of Science ®Google Scholar
• HwangKENaKSParkDSApoptotic induction by simvastatin in human lung cancer A549 cells via Akt signaling dependent down-regulation of survivinInvest New Drugs201129594595220464445
   PubMed Web of Science ®Google Scholar
• LiuHWangZLiYLiWChenYSimvastatin prevents proliferation and bone metastases of lung adenocarcinoma in vitro and in vivoNeoplasma2013600324024623373992
   PubMed Web of Science ®Google Scholar
• HanaiJDoroNSasakiATInhibition of lung cancer growth: ATP citrate lyase knockdown and statin treatment leads to dual blockade of mitogen-activated protein kinase (MAPK) and phosphatidylinositol-3-kinase (PI3K)/AKT pathwaysJ Cell Physiol201222741709172021688263
   PubMed Web of Science ®Google Scholar
• ChenJLiuBYuanJAtorvastatin reduces vascular endothelial growth factor (VEGF) expression in human non-small cell lung carcinomas (NSCLCs) via inhibition of reactive oxygen species (ROS) productionMol Oncol201261627222153388
   PubMed Web of Science ®Google Scholar
• ChenJLanTHouJAtorvastatin sensitizes human non-small cell lung carcinomas to carboplatin via suppression of AKT activation and upregulation of TIMP-1Int J Biochem Cell Biol201244575976922305890
   PubMed Web of Science ®Google Scholar
• HwangKEKwonSJKimYSEffect of simvastatin on the resistance to EGFR tyrosine kinase inhibitors in a non-small cell lung cancer with the T790M mutation of EGFRExp Cell Res2014323228829624631288
   PubMed Web of Science ®Google Scholar
• FialaOPesekMFinekJStatins augment efficacy of EGFR-TKIs in patients with advanced-stage non-small cell lung cancer harbouring KRAS mutationTumour Biol20153685801580525702091
   PubMedGoogle Scholar
• NielsenSFNordestgaardBGBojesenSEStatin use and reduced cancer-related mortalityN Engl J Med2012367191792180223134381
   PubMed Web of Science ®Google Scholar
• CardwellCRMcMenaminUHughesCMMurrayLJStatin use and survival from lung cancer: a population-based cohort studyCancer Epidemiol Biomarkers Prev201524583384125934831
   PubMed Web of Science ®Google Scholar
• SecklMJOttensmeierCHCullenMMulticenter, phase III, randomized, double-blind, placebo-controlled trial of pravastatin added to first-line standard chemotherapy in small-cell lung cancer (LUNGSTAR)J Clin Oncol201735141506151428240967
   PubMed Web of Science ®Google Scholar
• ManthravadiSShresthaAMadhusudhanaSImpact of statin use on cancer recurrence and mortality in breast cancer: a systematic review and meta-analysisInt J Cancer201613961281128827176735
   PubMed Web of Science ®Google Scholar
• LiXWuXBChenQStatin use is not associated with reduced risk of skin cancer: a meta-analysisBr J Cancer2014110380280724366301
   PubMed Web of Science ®Google Scholar
• NayanMPunjaniNJuurlinkDNStatin use and kidney cancer survival outcomes: a systematic review and meta-analysisCancer Treat Rev20175210511627992843
   PubMed Web of Science ®Google Scholar
• GrayRTColemanHGHughesCMurrayLJCardwellCRStatin use and survival in colorectal cancer: results from a population-based cohort study and an updated systematic review and meta-analysisCancer Epidemiol201645718127750068
   PubMed Web of Science ®Google Scholar
• WellsGSheaBO’ConnellDThe Newcastle–Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses2010 Available from: www.ohri.ca/programs/clinical_epidemiology/oxford_web.pptAccessed November 25, 2017
   Google Scholar
• HigginsJGreenSCochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [Updated March 2011]The Cochrane Collaboration; 2011 Available at: http://handbook-5-1.cochrane.orgAccessed March 16, 2015
   Google Scholar
• ViechtbauerWBias and efficiency of meta-analytic variance estimators in the random-effects modelJ Educ Behav Stat2005303261293
   Web of Science ®Google Scholar
• RaudenbushSWAnalyzing effect sizes: random-effects modelsCooperHHedgesLVValentineJCThe Handbook of Research Synthesis and Meta-analysis2nd edNew YorkSage2009295316
   Google Scholar
• HungMSChenICLeeCPStatin improves survival in patients with EGFR-TKI lung cancer: a nationwide population-based studyPLoS One2017122e017113728158206
   PubMed Web of Science ®Google Scholar
• LeeYGLeeJHJangJSKimJHPrognostic benefit of statin with or without metformin in elderly patients with advanced non-small cell lung cancer: a nationwide population-based outcome studyJ Clin Oncol20173515_supple20661
   Web of Science ®Google Scholar
• LohinaiZDomePSzilagyiZFrom bench to bedside: attempt to evaluate repositioning of drugs in the treatment of metastatic small cell lung cancer (SCLC)PLoS One2016111e014479726735301
   PubMed Web of Science ®Google Scholar
• HuangWYLiCHLinCLLiangJALong-term statin use in patients with lung cancer and dyslipidemia reduces the risk of deathOncotarget2016727422084221427283991
   PubMedGoogle Scholar
• LinJJEzerNSigelKMhangoGWisniveskyJPThe effect of statins on survival in patients with stage IV lung cancerLung Cancer20169913714227565929
   PubMed Web of Science ®Google Scholar
• LeeYLeeKHLeeGKRandomized phase II study of afatinib plus simvastatin versus afatinib alone in previously treated patients with advanced nonadenocarcinomatous non-small cell lung cancerCancer Res Treat20174941001101128111428
   PubMed Web of Science ®Google Scholar
• LamVKBentzenSMMohindraPObesity is associated with long-term improved survival in definitively treated locally advanced non-small cell lung cancer (NSCLC)Lung Cancer2017104525728213000
   PubMed Web of Science ®Google Scholar
• WangAAragakiAKTangJYStatin use and all-cancer survival: prospective results from the Women’s Health InitiativeBr J Cancer2016115112913527280630
   PubMed Web of Science ®Google Scholar
• MaimonNKeizmanDGottfriedMStatins (ASIs) may improve the outcome of erlotinib as second line treatment (tx) in patients (pts) with metastatic non-small cell lung cancer (mNSCLC)J Clin Oncol20123015_Supple18108
   Google Scholar
• RamakrishnaSAndreiACVarlottoJStatin use is associated with decreased local recurrence and improved overall survival in resectable non-small cell lung cancer (NSCLC)Chest20121424925A925B
   Google Scholar
• HanJYLeeSHYooNJA randomized phase II study of gefitinib plus simvastatin versus gefitinib alone in previously treated patients with advanced non-small cell lung cancerClin Cancer Res20111761553156021411446
   PubMed Web of Science ®Google Scholar
• HanbaliASWangDJankowskiMThe use of statins may prolong survival of non-small cell lung cancer patients: final update from 1,205 casesJ Clin Oncol200718_suppl7638
   Google Scholar
• LeighlNBPaz-AresLDouillardJYRandomized phase III study of matrix metalloproteinase inhibitor BMS-275291 in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: National Cancer Institute of Canada-Clinical Trials Group Study BR. 18J Clin Oncol2015231228312839
   Web of Science ®Google Scholar
• ShepherdFARodrigues PereiraJCiuleanuTErlotinib in previously treated non-small-cell lung cancerN Engl J Med2005353212313216014882
   PubMed Web of Science ®Google Scholar
• HagueWESimesJKirbyALong-term effectiveness and safety of pravastatin in patients with coronary heart disease: sixteen years of follow-up of the LIPID studyCirculation2016133111851186027016105
   PubMed Web of Science ®Google Scholar
• LiangYWChangCCHungCMChenTYHuangTYHsuYCPreclinical activity of simvastatin induces cell cycle arrest in G1 via blockade of cyclin D-Cdk4 expression in non-small cell lung cancer (NSCLC)Int J Mol Sci20131435806581623481641
   PubMed Web of Science ®Google Scholar
• YuXPanYMaHLiWSimvastatin inhibits proliferation and induces apoptosis in human lung cancer cellsOncol Res201320835135723924855
   PubMed Web of Science ®Google Scholar
• WangJLiCTaoHStatin use and risk of lung cancer: a meta-analysis of observational studies and randomized controlled trialsPLoS One2013810e7795024205041
   PubMed Web of Science ®Google Scholar
• TanMSongXZhangGStatins and the risk of lung cancer: a meta-analysisPLoS One201382e5734923468972
   PubMed Web of Science ®Google Scholar